Current Appointments & Affiliations
Professor of Neurology
·
2018 - Present
Neurology, Neuromuscular Disease,
Neurology
Director of EMG Lab Services in the Department of Neurology
·
2006 - Present
Neurology,
Clinical Science Departments
Division Chief, Neuromuscular Disease in the Department of Neurology
·
2015 - Present
Neurology,
Clinical Science Departments
Recent Publications
The Duke MG Patient Registry III. Comparative Effectiveness of Azathioprine and Mycophenolate Mofetil in Generalized Myasthenia Gravis, a Retrospective Single Center Review.
Conference Muscle Nerve · February 17, 2026 INTRODUCTION/AIMS: Azathioprine (AZA) and mycophenolate mofetil (MMF) are the most commonly used non-steroidal immunosuppressants in patients with generalized myasthenia gravis (gMG) in North America but their relative effectiveness among disease subgroups ... Full text Link to item CiteA Distinct Immunological Signature in Late-Onset Myasthenia Gravis: Insights from an Exploratory Proteomics Study.
Journal Article Ann Neurol · January 2026 OBJECTIVE: Approximately 80% of patients with myasthenia gravis (MG) have autoantibodies against acetylcholine receptor, and clinical characteristics may vary between early-onset (symptom onset age <50 years) and late-onset MG (EOMG and LOMG), but the path ... Full text Link to item CiteMills' syndrome and myasthenia gravis: a case report.
Journal Article Neuromuscul Disord · November 2025 A 50-year-old man with hypothyroidism was referred for refractory myasthenia gravis (MG). He developed progressive, painless right-sided shoulder and leg weakness, dysphagia, and fatigable diplopia. Acetylcholine receptor (AChR) antibodies were positive. I ... Full text Link to item CiteRecent Grants
Capture MG
ResearchPrincipal Investigator · Awarded by The George Washington University · 2025 - 2030DNA08: ARGX-113-2315
Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2025 - 2030DNA05 Argenx_ARGX-113-2308: A randomized, double-blinded, placebo-controlled, phase 3, parallel group design study evaluating the efficacy and safety of efgartigimod IV in adult participants with acetylcholine receptor binding antibody (AChR-Ab)
Clinical TrialPrincipal Investigator · Awarded by Argenx BVBA · 2024 - 2029View All Grants
Education
University of Illinois ·
1989
M.D.